Almokalant
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
4-(3-{Ethyl[3-(propane-1-sulfinyl)propyl]amino}-2-hydroxypropoxy)benzonitrile | |
| Identifiers | |
| CAS Number |
123955-10-2 |
| ATC code | None |
| PubChem | CID 3033962 |
| ChemSpider |
2298526 |
| UNII |
I9NG89L275 |
| ChEMBL |
CHEMBL362103 |
| Chemical data | |
| Formula | C18H28N2O3S |
| Molar mass | 352.5 g/mol |
| |
| |
| (verify) | |
Almokalant is drug used to treat arrhythmia.[1] It is a potassium channel blocker. It has been found to have teratogenic effects in rats.[2]
References
- ↑ Wiesfeld A C; Crijns H J; Bergstrand R H; Almgren O; Hillege H L; Lie K I (1993). "Torsades de pointes with Almokalant, a new class III antiarrhythmic drug". American Heart Journal 126 (4): 1008–1011. doi:10.1016/0002-8703(93)90726-p.
- ↑ Wellfelt, K.; Sköld, A. C.; Wallin, A.; Danielsson, B. R. (1999-04-01). "Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species". Reproductive Toxicology (Elmsford, N.Y.) 13 (2): 93–101. ISSN 0890-6238. PMID 10213516.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
